Stay updated on Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial page.

Latest updates to the Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial page
- Check3 days agoChange DetectedAdded related topics: Lung cancer and MedlinePlus Genetics to the page, providing quick access to disease context and genetics resources.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page now displays Revision: v3.5.0, replacing the previous Revision: v3.4.3.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check54 days agoChange DetectedAdded Revision: v3.4.2. Removed references to Lung cancer, related topics, MedlinePlus Genetics, and Revision: v3.4.1.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision: v3.4.1 was added, and Lung cancer, related topics, MedlinePlus Genetics, and Revision: v3.4.0 were removed.SummaryDifference0.1%

- Check75 days agoChange DetectedUI text updates include added options to show or hide the glossary, and new labels 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. Old items such as 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' have been removed.SummaryDifference0.1%

Stay in the know with updates to Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Chemotherapy in Relapsed SCLC - Clinical Trial page.